Additionally, NOTCH3 could be identified as parameter for predicting therapy response to gemcitabine in pancreatic cancer: expression of NOTCH3 inversely correlated with therapy response and overall survival of patients treated with gemcitabine (Eto et al. 2013). Here, NOTCH3 is linked to familial pancreatic carcinoma.